Mushrooms: Brain Bleeding Risk?

Magic mushrooms are hallucinogenic drugs that alter the chemical composition of the brain's cells, resulting in a profound shift in perception and sensation. Psilocybin, the active ingredient in magic mushrooms, has been found to decrease blood flow and connectivity between brain regions responsible for perception and cognition. While the drug has shown potential in treating depression and anxiety, particularly in end-stage cancer patients, its impact on the brain has raised concerns. Research suggests that regular interference with serotonin, a key chemical in the brain, could lead to long-term changes in brain function. Additionally, there have been reports of psilocybin-induced headaches and migraines, with one case study suggesting a link between magic mushroom abuse and subarachnoid hemorrhage, a rare form of cerebrovascular accident.

Psilocybin decreases blood flow

Psilocybin, the active ingredient in magic mushrooms, has been found to decrease blood flow to the brain. This was discovered in a 2011 study by Robin Carhart-Harris of Imperial College London, which was the first time psilocybin's effects had been measured with fMRI. The study also found that psilocybin decreased connectivity between important areas of the brain that control perception and cognition, including the thalamus, the posterior cingulate, and the medial prefrontal cortex. These areas can be overactive in people with depression, which may explain why psilocybin has potential as a treatment for the condition.

The study involved 30 volunteers who agreed to be injected with psilocybin and have their brains scanned using two types of fMRI. One group had their blood flow measured during the resulting trip, while the other group underwent a scan that measured connectivity between different regions of the brain. The results showed that psilocybin not only decreased blood flow to the brain but also reduced connectivity between key regions.

Further research has supported these findings, with some studies reporting that psilocybin induced decreases in cerebral blood flow (CBF) in various regions of the brain, including parietal, limbic, and frontal areas. One study found that psilocybin caused a significant decrease in the positive coupling between the medial prefrontal cortex (mPFC) and the posterior cingulate cortex (PCC), which are key connector hubs in the brain. This decrease in activity and connectivity is believed to enable the state of unconstrained cognition experienced during psilocybin trips.

While the immediate effects of psilocybin may not be as important for its clinical benefit, its ability to increase the expression of genes and signalling proteins associated with nerve growth and connectivity may underlie its therapeutic potential. For example, psilocybin's structural similarity to serotonin, a hormone involved in regulating mood, allows it to bind to serotonin receptors on nerve cells in the brain. This may explain why psilocybin has been found to reduce anxiety and improve mood in people with end-stage cancer.

Hallucinogenic effects

Hallucinogenic drugs like mushrooms can cause profound shifts in perception and sensation. The active ingredient in magic mushrooms, psilocybin, decreases blood flow and connectivity between areas of the brain that control perception and cognition. This can result in hallucinations, with users reporting that they are seeing sounds or hearing colours.

Psilocybin has a chemical structure similar to serotonin, a hormone that regulates mood and other vital body functions. By binding to serotonin receptors, psilocybin alters the chemical composition of brain cells, removing the "chemical blinders" that normally preprocess sensory information. This can lead to a mind-altering experience where every bit of data is presented to the consciousness.

The effects of psilocybin on the brain have been studied using functional magnetic resonance imaging (fMRI). These studies have found that psilocybin disrupts connectivity across cortical networks and subcortical structures, particularly in the default mode network (DMN), which is connected to the anterior hippocampus and involved in creating our sense of self. The drug also induces a persistent decrease in functional connectivity between the anterior hippocampus and cortex, which may be related to its antidepressant effects.

While the long-term effects of psilocybin are still being studied, some research suggests that it could have therapeutic potential. For example, a study by Charles Grob at the University of California, Los Angeles, found that people with end-stage cancer had reduced anxiety and improved moods after receiving psilocybin. Additionally, a five-year study suggested that psilocybin could work "like a surgical intervention" for mental illness, particularly depression and anxiety. However, there are also concerns about the potential negative consequences of psilocybin use, including the risk of triggering mental illness or long-lasting psychosis.

Serotonin changes

While there is no evidence that mushrooms cause brain bleeding, they do have a profound impact on the brain. Psilocybin, the active ingredient in magic mushrooms, has been shown to decrease blood flow and connectivity between important areas of the brain that control perception and cognition. This can result in a mind-altering experience, with hallucinations, feelings of detachment, and an inability to discern fantasy from reality.

Psilocybin has a similar chemical structure to serotonin, a hormone that regulates mood and other vital body functions, including heart rate. By binding to serotonin receptors in the brain, psilocybin alters the chemical composition of brain cells, resulting in a "trip" that can last for hours. During this time, portions of the brain fire at different rates, and the brain is flooded with data that would usually be pre-processed. This can lead to an altered perception of self, time, and space, as well as emotional and cognitive changes.

Research suggests that regular interference with serotonin could change the way the brain works in the long term. For example, psilocybin has been shown to increase the expression of genes associated with nerve growth and connectivity, which may contribute to its potential therapeutic effects in treating depression and anxiety, particularly in end-stage cancer patients. However, it is important to note that psilocybin can also have negative impacts on mental health, and its long-term effects on serotonin and the brain are not yet fully understood.

While psilocybin can induce powerful changes in brain networks, these changes are not always negative. In some cases, they may even be beneficial. For example, psilocybin has been shown to decrease functional connectivity between the anterior hippocampus and cortex, which may contribute to its antidepressant effects. Additionally, in clinical trials, a single high dose of psilocybin has demonstrated immediate and sustained symptom relief in depression. However, more research is needed to fully understand the complex interactions between psilocybin, serotonin, and the brain.

Potential brain damage

While there is no evidence that mushrooms cause brain bleeding, there are still concerns about the potential brain damage that can be caused by their consumption. Mushrooms are hallucinogenic drugs that alter the chemical composition of the brain's cells. They produce profound shifts in perception and sensation, creating the "trip" experience that can last for hours. Psilocybin, the active ingredient in magic mushrooms, decreases blood flow and connectivity between areas of the brain that control perception and cognition.

Research suggests that regular interference with serotonin, a key chemical in the brain's cells, could lead to long-term changes in how the brain functions. Serotonin plays a role in regulating vital body functions, such as heart rate, and alterations in its levels can result in heart difficulties and overheating. Additionally, psilocybin's impact on the brain's network structure can be significant, with changes exceeding those induced by other state changes. These changes can include a persistent decrease in functional connectivity between the hippocampus and cortex, which may contribute to the drug's antidepressant effects.

The impact of mushrooms on memory is also a concern. Studies suggest that portions of the brain fire at different rates when influenced by mushrooms, potentially leading to false memories or embellished recollections. The drug's ability to induce hallucinations, feelings of detachment, and an inability to discern fantasy from reality further underscores the potential for adverse psychological effects.

Moreover, the risk of brain damage is heightened when mushrooms are combined with other substances or when individuals consume wild mushrooms without proper identification, as this could lead to the ingestion of toxic varieties. While the immediate effects of psilocybin are important, it is the longer-term effects that may be more clinically significant in understanding potential brain damage.

Headaches and nausea

The active ingredient in magic mushrooms, psilocybin, has been associated with headaches and nausea. While there are no reports of subarachnoid hemorrhage (SAH) caused by psilocybin in the literature, a case report has linked its use to SAH, a rare type of cerebrovascular accident that accounts for 5% of strokes in young individuals and has a high mortality rate.

Psilocybin has been found to decrease blood flow and connectivity in brain regions that control perception and cognition. This can lead to mind-altering experiences, such as hallucinations and feelings of detachment, which may contribute to headaches and nausea. A study by Johnson et al. reported delayed and transient headaches in healthy volunteers after psilocybin exposure, suggesting a correlation between psilocybin and headaches. However, the mechanism behind psilocybin-induced headaches remains unclear.

The effects of psilocybin on the brain are complex and involve interactions with serotonin receptors, specifically the 5-HT2A receptor. Serotonin plays a crucial role in regulating vital body functions, including heart rate. Regular interference with serotonin through psilocybin use could potentially change the way the brain functions in the long term, leading to unknown consequences.

Additionally, the intensity and duration of psilocybin effects vary depending on individual metabolism. While the mind-altering effects typically last up to 8 hours, cognitive and emotional changes can persist beyond this period. Some individuals may experience drug-induced psychosis, flashbacks, or other adverse events, underscoring the importance of understanding the risks associated with psilocybin use.

It is worth noting that the potential dangers of magic mushrooms may also arise from the addition of other substances by dealers or the consumption of the wrong type of mushroom by individuals foraging for their own mushrooms. These factors can increase the risk of adverse effects, including headaches and nausea.

Frequently asked questions